Nanox recently announced an agreement with CureMetrix to provide AI-based diagnostic systems to support the Nanox Cloud Platform. This collaboration will enable Nanox to leverage the power of AI-based diagnostics to improve the accuracy and speed of medical diagnostics.
Combining these two technologies will allow healthcare providers to obtain critical imaging data faster and more accurately, improving patient outcomes.
Nanox Announces Agreement With CureMetrix For AI-based Assistive Diagnostic Tool to Support Nanox Cloud Platform
Nanox, a leading innovator in Digital X-Ray Imaging, has announced a strategic agreement with CureMetrix, a healthcare technology company to develop an AI-based ‘Assistive Diagnostic Tool’ to support the newly released Nanox Cloud Platform. This development is part of its ongoing efforts to transform healthcare through its revolutionary Digital Medical Imaging products.
The Nanox Cloud Platform is a medical imaging ecosystem allowing hospitals and clinics to access state-of-the-art 3D full body Digital X Ray imaging for diagnostics. It combines cloud computing with hardware, software and services to offer low cost and low maintenance digital medical imaging across multiple sites irrespective of geographic location or size. With this platform, healthcare providers can now share the latest information about the well being of their patients digitally with other supportive professionals like orthopaedics or radiologists without any time lag or security concerns. In many cases, this could even save lives as diagnoses can be made instantly no matter which part of the world they originate from.
The development of the AI-based ‘Assistive Diagnostic Tool’ will add another exciting layer of functionality to this already advanced product offering by helping simplify data management and allowing on-the-spot disease recognition based on real-time patient images, thus enhancing accuracy and accuracy speed. This collaboration between Nanox and CureMetrix reinforces Nanox’s core mission to provide exceptional quality patient care around the world using cutting-edge technology, resulting in positive outcomes for all stakeholders like patients, clinicians & physicians alike.
Overview of CureMetrix AI-based Assistive Diagnostic Tool
Nanox has agreed with CureMetrix to incorporate their AI-based Assistive Diagnostic Tool into the Nanox Cloud Platform. This will help empower radiology professionals to simplify and streamline diagnostics and improve accuracy through AI-assisted imaging analysis.
CureMetrix AI-based Assistive Diagnostic Tool offers features to support improved productivity, accuracy and precision in coronary artery disease and other medical conditions. It was developed using deep learning and advanced analytics to provide real-time image analysis, resulting in more accurate diagnoses. For example, using convolutional neural networks (CNNs) it assesses coronary artery calcium scores in patients with high risk of heart attack or stroke within seconds. In addition, the tool assigns confidence levels of these assessments, helping clinicians make decisions quickly and accurately.
This powerful diagnostic tool presents numerous benefits for end users of the Nanox Cloud platform including faster patient turnover, fewer false positives/negatives, improved adherence rates for treatment plans, quick diagnosis confirmation through confidence levels assigned by the tool and improved productivity for healthcare providers as well as radiologists involved in diagnostic analysis.
Benefits of AI-based Assistive Diagnostic Tool
Nanox recently announced an agreement with CureMetrix to implement an AI-based assistive diagnostic tool to support the Nanox Cloud Platform. This partnership will help to advance the use of AI in the medical field by offering an AI-based assistive diagnostic tool that will enable more accurate and efficient diagnosis of various pathologies.
This agreement will bring together the strengths of Nanox and CureMetrix to create a tool that will revolutionise the medical industry and help provide more accurate diagnoses and treatments.
Let’s look at the benefits of this AI-based assistive diagnostic tool.
Improved accuracy in medical imaging
The NanoCloud Platform of Nanox is supported by an AI-based assistive diagnostic tool from CureMetrix. The tool uses sophisticated AI algorithms to analyse medical imaging and provide actionable insights to healthcare professionals. Having this technology at hand greatly reduces the margin of error when diagnosing medical conditions.
AI-based assists are adept in handling manual workloads, such as sifting through complex medical imaging data, tracking patient progress over time, and analysing disease progression. Medical imaging in the healthcare system is a very data-intensive task; AI- based assistance can help with this task, providing accurate diagnoses within tight timeframes.
AI assistance enables full automation of repetitive tasks that require manual input so that human expertise can be released for more complicated tasks. This leads to faster diagnosis times and allows any irregularities to be identified quicker than if done manually without making any mistakes. Thus, there is an exponential increase in accuracy from using AI tools for analysing medical images.
These tools have cross-specialty applications and are used for more than just diagnostics, research, and prevention of various illnesses and diseases. Using AI technology helps reduce time spent on administrative routine tasks such as gathering statistics on common diseases or researching new treatments for rare diseases; allowing physicians and other healthcare personnel to focus on the more complicated areas such as patient care, furthering research and looking into preventive measures when needed or applicable. The use of artificial intelligence technologies offers a much higher accuracy rate than traditional methods with improved speeds as well due to automation capabilities; which in turn improves patient outcomes significantly by increasing accuracy while still preserving an optimal workflow even at peak traffic demand periods within hospitals and health systems globally due to pandemics or other emergency cases or situations when healthcare resources need scale up quickly but accurately confirming diagnosis before taking any next steps regarding treatment or further tests saving precious lives at stake.
Reduced time for diagnosis
Nanox and CureMetrix recently agreed on an AI-based assistive diagnostic tool to support Nanox Cloud Platform. This agreement will allow the patient data to be fed into the AI-based diagnostic tool, which then provides a summarised report of the patient’s condition, helping physicians to make quicker decisions.
The AI-based Assistive Diagnostic Tool can help reduce diagnosis time by parsing through large amounts of complex data more quickly and accurately than any human could. Because it works with the Nanox Cloud Platform, it can provide up-to-date insights into the patient’s condition, allowing physicians to respond faster by drawing upon current diagnostic datasets. In addition, these datasets provide a snapshot of clinical knowledge from across different medicine domains and clinical specialties that helps make evidence–based medical decisions.
In addition, with less time spent on diagnostics, patients will experience shorter wait times for results and better accessibility to healthcare solutions at a lower cost. With faster turnaround times for diagnoses also comes higher chances for successful treatments since conditions do not have as much time to worsen before diagnosis or treatment begins.
Reduced cost of medical imaging
Nanox and CureMetrix have partnered to integrate an AI-based assistive diagnostic tool into the Nanox Cloud Platform. This tool will reduce the cost of medical imaging by providing radiologists with more accurate and timely diagnosis of patient scans. The AI-based assistive diagnostic tool uses advanced artificial intelligence algorithms to compare patient data against millions of prior images to identify unusual or abnormal results.
AI-driven fast diagnosis can reduce the radiologist’s time spent on each case. This is especially beneficial for districts or countries with limited access to radiologists, as it allows them to better serve patients without additional human resources. Furthermore, AI software can help reduce errors and minimise missed findings due to human fatigue or oversight.
The benefit goes beyond patient care: reduced time spent per case translates into increased efficiency and lower costs for facilities that use the Nanox Cloud System. Automation at this level is especially helpful when processing medical images resulting from high volumes of tests, such as those predicted in the US and other countries post-COVID 19 pandemic. By playing a role in lowering diagnostic costs, Nanox’s AI-based Assistive Diagnostic Tool can help make healthcare more accessible and possibly more affordable in many countries around the world going forward.
How AI-based Assistive Diagnostic Tool Will Support Nanox Cloud Platform
Nanox, a digital medical imaging device company, has agreed with CureMetrix to provide an AI-based Assistive Diagnostic Tool (ADT) to be integrated into its Nanox Cloud platform. The partnership will leverage AI and deep learning to simplify medical imaging workflow and deliver real-time decision support.
This article will outline how the AI-based Assistive Diagnostic Tool will support the Nanox Cloud Platform.
Improved data security
Data security is one of healthcare organisations’ top concerns, particularly when data breaching frequently occurs. As a result, Nanox has partnered with CureMetrix to bring an AI-based Assistive Diagnostic Tool (ADT) to its cloud platform to ensure that customer data remains secure and private. With this new solution in place, customer information will be better protected which will help improve the overall security of customer data.
The ADT solution is designed to detect irregular patterns or abnormalities in customers’ medical images and reports while preserving the complete privacy of customer data. With its innovative machine learning algorithms, ADT can detect discrepancies between normal and abnormal in a medical image or report. As soon as it detects anything out of the ordinary, it can take appropriate measures, based on the level of abnormality detected and action agreed upon by Nanox’s policy for such scenarios. Additionally, ADT provides access control logic for maintaining data security across all cloud platforms.
AI-based Assistive Diagnostic Tool (ADT) will also offer healthcare organisations increased accuracy when making critical health decisions based on diagnostic imaging-related reports and patient information within the platform. The technology behind this tool works together to ensure customer’s confidential medical data remains secure while stored within Nanox’s cloud platform system.
Improved access to medical imaging
Nanox is proud to announce its collaboration with CureMetrix, a leading developer of artificial intelligence (AI) services for medical imaging, to provide an AI-based assistive diagnostic tool. This tool will assist radiologists in detecting abnormalities on imaging studies using the Nanox Cloud platform.
The agreement calls for CureMetrix’s flagship product, Figure 1-CXR (Fig1), to be integrated with the Nanox Cloud platform. The integration of Fig1 will provide Clinical Decision Support (CDS) by leveraging machine learning and computer vision technology to enable improved access to medical imaging diagnosis.
In particular, the partnership offers AI-enabled analysis of x-ray images, allowing radiologists and clinicians to more accurately detect lesions, fractures and other abnormalities associated with Chest X Ray radiology cases. This includes automated detection from aChest X Ray scan combined with Artificial Intelligence software powered by deep learning algorithms that make it easier for radiologists to quickly frame diagnosis when time is of the essence.
Moreover, leveraging the advanced technology provided by Fig1 allows Physicians and Radiologists access to advanced research protocols in real time. Radiologists can seamlessly monitor patient follow up scans during their course of treatment by taking advantage of multi-level patient tracking enabled on Nanox’s cloud platform. Fig1 also provides documentation tools for follow up reports required for public healthcare standards thus allowing physicians more robust access to data intelligence across multiple network devices including desktops as well as mobile devices such as smartphones and tablets making it easier for collaboration between health care professionals regardless of geographical locations among other benefits.
Overall, this alliance further highlights nanox ambition toward becoming one system solutions provider in the world’s healthcare imaging industry through supplying high quality anatomical analysis with minimised wait times and increased accuracy — ultimately improving patient satisfaction in healthcare delivery worldwide.
Automated workflow
The automated workflow feature of Nanox Cloud’s AI-based assistive diagnostic tool allows radiologists and imaging teams to collaborate more precisely and quickly. The platform’s automated workflow allows professionals to view AI-annotated images in a fraction of the time normally taken to detect abnormalities. The new automated workflow also enables a single radiologist to check patient images in far less time, freeing them up to work on more life-saving tasks.
Furthermore, the automated workflow helps alleviate diagnostic errors by highlighting additional findings that may have been overlooked. By providing a comprehensive picture of the patient’s condition, radiologists are more likely to make accurate assessments much sooner–leading to potentially enhanced patient care outcomes and outcomes for medical facilities.
The Nanox Cloud enablement platform is built to take advantage of ‘artificial intelligence’ technologies from numerous such industry partners as IBM Watson and Microsoft Azure ‒ offering unmatched performance with innovative features like image analysis that can scan medical data for diagnostically useful patterns, telehealth functionality leveraging cloud based immersive 3D imaging along with an array of other premium diagnostic tools for superior healthcare decision making. The advanced AI capabilities along with CureMetrix’s medical image analysis technology will open up greater opportunities for evidence based decision making on anatomical abnormalities related across all modalities including Ultrasound (US), Chest X-ray (CXR), Positron Emission Tomography Computed Tomography (PET/CT) etc.
About The Author
